Author:
Chang Hong,Meng Hong-yu,Liu Shu-min,Wang Yu,Yang Xiao-xu,Lu Fang,Wang Hong-yu
Publisher
Springer Science and Business Media LLC
Reference47 articles.
1. Schuppan, D. & Kim, Y. O. Evolving therapies for liver fibrosis. J Clin Invest 123, 1887–1901 (2013).
2. Zhou, W. C., Zhang, Q. B. & Qiao, L. Pathogenesis of liver cirrhosis. World J Gastroenterol 20, 7312–7324 (2014).
3. Xu, R., Zhang, Z. & Wang, F. S. Liver fibrosis: mechanisms of immune-mediated liver injury. Cell Mol Immunol 9, 296–301 (2012).
4. Huang, H. et al. Serum metabolomic signatures discriminate early liver inflammation and fibrosis stages in patients with chronic hepatitis B. Sci Rep 6, 30853 (2016).
5. Xiang, Z., Sun, H., Cai, X. J. & Chen, D. H. The study on serum and urine of renal interstitial fibrosis rats induced by unilateral ureteral obstruction based on metabonomics and network analysis methods. CrossMark 408, 2607–2619 (2016).
Cited by
69 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献